Hyperbaric Oxygen Therapy and Male Fertility

Article
Dr Nur's profile photo
DrNur Ozyilmaz, MD
Founder · NUMA

Quick summary

Hyperbaric oxygen therapy (HBOT) is emerging as a promising adjunct in male fertility care when sperm quality is a major barrier to conception. It is best used as part of a comprehensive fertility strategy, rather than replacing standard evaluation and treatment. The overall direction of the evidence is encouraging: HBOT has been associated with better sperm survival, count, motility, morphology, DNA integrity, and and, in some studies, pregnancy outcomes in selected men, particularly where oxidative stress, sperm DNA fragmentation, varicocele-related dysfunction, or idiopathic infertility are part of the picture 1 2 3 4.

What is HBOT?

HBOT is a medical treatment in which a patient breathes near pure oxygen inside a pressurized chamber. In male fertility, the rationale is straightforward: sperm production and sperm function depend on a healthy testicular environment, good microcirculation, controlled inflammation, and balanced oxidative stress. By improving tissue oxygen delivery, HBOT may help support those conditions 1.

The role of HBOT in male fertility

Male infertility is often more than a numbers problem. In many men, the issue is sperm function: poor motility, membrane damage, oxidative stress, impaired oxygenation of testicular tissue, or high sperm DNA fragmentation. HBOT is particularly interesting in this setting because it may improve oxygen delivery, support microcirculation, reduce oxidative injury, and create a healthier environment for sperm development and maturation 1 3 5.

In practical terms, HBOT may enhance sperm viability, improve motility, and reduce oxidative stress and DNA damage. That is why it appears most relevant in men with poor motility, high DNA fragmentation, oxidative-stress patterns, varicocele-related infertility, idiopathic male infertility, or fertility plans where better sperm quality could meaningfully improve natural conception or assisted reproduction outcomes 1 2 3.

Biological rationale

HBOT appears to support male fertility through several complementary mechanisms:

  • Improves sperm quality - Enhances sperm count, motility, and overall structure 1 2.
  • Supports sperm survival - Promotes a healthier testicular environment, improving sperm viability 1.
  • Reduces oxidative stress - Lowers reactive oxygen species that impair sperm function 3.
  • Improves DNA integrity - Reduces sperm DNA fragmentation, a key driver of poor fertilization and miscarriage 3.
  • Enhances the reproductive environment - Improves microcirculation and oxygen delivery to testicular tissue 1 2.
  • Improves clinical outcomes - Associated in some studies with higher pregnancy rates and improved outcomes in assisted reproduction 1 3 4.

Taken together, these findings suggest that HBOT may help improve the underlying biological drivers of male fertility, particularly in men with oxidative stress, DNA damage, or functional sperm impairment. The results are encouraging and clinically relevant, although further high-quality studies are needed to define optimal protocols and long-term outcomes 1 3 4.

What the evidence shows

The most comprehensive overview comes from a 2025 systematic review and meta-analysis of nine studies. Across those studies, HBOT was consistently associated with improvements in sperm survival, count, motility, morphology, and clinical pregnancy rate. Just as importantly, the overall pattern was broad rather than isolated, suggesting that HBOT may support overall sperm function rather than acting on only one parameter 1.

Individual studies provide additional clinical context. In men with varicocele-related infertility, the addition of HBOT to varicocelectomy has been associated with improvements in semen quality, reproductive hormone profiles, sperm functional capacity, pregnancy rates, and time to conception compared with surgery alone 2.

In men with idiopathic infertility undergoing IVF, HBOT has been associated with a significant reduction in sperm DNA fragmentation and reactive oxygen species, alongside higher pregnancy rates compared with control groups. This is one of the clearest human signals that HBOT may help when oxidative stress and sperm DNA damage are central to the fertility problem 3.

A smaller pilot study integrating HBOT with assisted reproductive treatment reported favorable findings, including improvements in sperm count in some patients, positive changes in selected surgical sperm retrieval cases, and pregnancies following treatment. While limited in size, it provides a practical example of how HBOT may be incorporated into a fertility pathway 4.

Laboratory and animal studies support a similar biological direction. Hyperbaric exposure has been associated with improved sperm motility in ex vivo samples, and animal models have demonstrated improved sperm parameters alongside reduced oxidative stress and inflammation within the testes 6 5.

When to start HBOT

Timing is an important consideration, as spermatogenesis is a prolonged process and the effects of HBOT are unlikely to be fully realized if used immediately prior to conception attempts. A practical clinical window is approximately 8 to 12 weeks before attempting conception, or before sperm collection for IUI, IVF, ICSI, TESE, or micro-TESE. This allows time for improved sperm to develop and appear in the ejaculate 3 4.

There is currently no single standardized fertility protocol. Published studies describe shorter treatment courses in some settings, alongside longer durations in others. The key principle is to begin early enough to influence a full spermatogenic cycle and to integrate HBOT within a clearly defined fertility plan 1 3 4.

Care strategy

A structured, goal-driven approach is recommended:

  • Define the male-factor pattern clearly - Men with poor motility, high sperm DNA fragmentation, oxidative-stress features, idiopathic infertility, or clinically significant varicocele are the most appropriate candidates for HBOT 1 2 3.
  • Start early enough to matter - HBOT is most effective when implemented in advance of the intended conception window or assisted reproductive cycle, rather than immediately prior 3 4.
  • Use HBOT to support a clearly defined fertility objective --- whether improving semen quality prior to natural conception, optimizing sperm parameters before IUI, enhancing DNA integrity before IVF or ICSI, or supporting recovery of the testicular environment following varicocele repair 2 3 4.
  • Measure response objectively - Repeat semen analysis and, where appropriate, sperm DNA fragmentation testing after an appropriate interval to assess whether biological changes translate into measurable clinical change, under specialist guidance. 1 3.

Summary

HBOT is an emerging adjunct in male fertility care, with evidence suggesting potential improvements in sperm quality and, in selected men, pregnancy outcomes. When integrated with standard care, it may help support a more favorable biological environment for conception or assisted reproduction 1 2 3 4.

The overall evidence base is encouraging and supported by both clinical and mechanistic data. HBOT should be considered an adjunct rather than a replacement for standard fertility care. Further high-quality, large-scale studies are needed to define optimal use, identify patients most likely to benefit, and clarify its impact on live birth and long-term reproductive outcomes. 1 6 5.

This information is intended for educational purposes and should not replace consultation with a qualified fertility specialist or urologist. Treatment decisions should be based on individual clinical assessment.

References

Footnotes

  1. Liu B, Wang J, Liu L, Lv M, Zhou D, Li M. Hyperbaric oxygen therapy for male infertility: a systematic review and meta-analysis on improving sperm quality and fertility outcomes. Medical Gas Research. 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12124701/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15
  2. Zheng RQ, Wang XS, Wang PT. Effect of varicocelectomy with hyperbaric oxygenation in treating infertile patients with varicocele. 2006. https://pubmed.ncbi.nlm.nih.gov/16483159/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8
  3. Metelev AY, Bogdanov AB, Ivkin EV, Mitrokhin AA, Vodneva MM, Veliev EI. Hyperbaric oxygen therapy in the treatment of male infertility associated with increased sperm DNA fragmentation and reactive oxygen species in semen. 2015. https://journals.eco-vector.com/1728-2985/article/view/282260 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9 ↩10 ↩11 ↩12 ↩13 ↩14 ↩15
  4. Ozgok Kangal K, Ozgok Y. Assisted reproductive treatments with hyperbaric oxygen therapy in male infertility. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8018801/ ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8 ↩9
  5. Liu H, Wang D, Ma Y, et al. Hyperbaric oxygen therapy ameliorates sperm parameters in apolipoprotein E knockout mice testes by attenuating oxidative stress and inflammation. 2023. https://pubmed.ncbi.nlm.nih.gov/36745359/ ↩ ↩2 ↩3
  6. Mitrovic A, Brkic P, Jovanovic T. The effects of hyperbaric oxygen treatment on vigility of spermatozoids: preliminary report. 2011. https://pubmed.ncbi.nlm.nih.gov/21388934/ ↩ ↩2